Johnson & Johnson's agreement with the Trump administration enables patients to access drugs at a comparable price to other ...

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced ...

Schreiner MediPharm, a developer and manufacturer of functional labels for the healthcare industry, has expanded its Needle-Trap needle protection system.

Magali Haas, MD, PhD, founded Cohen Veterans Bioscience and worked at Johnson & Johnson before becoming Psilera's new Chief ...

Halozyme Therapeutics Inc. has entered into a global collaboration and exclusive license agreement with Takeda.

Veeva Systems and BioMarin Pharmaceutical have announced an enterprise agreement intended to build upon their long-standing ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

Evotec SE’s Seattle-based subsidiary, Just – Evotec Biologics Inc., has received a new grant from the Gates Foundation to ...

Rentschler to manufacture VarmX’s VMX-C001 for Phase 3 development and potential commercialization.